SEMAX

SEMAX

    $29.95

    A 7-amino acid synthetic heptapeptide analog of ACTH (4-10) that upregulates BDNF expression and modulates the TrkB signaling pathway, studied for cognitive enhancement and neuroprotection in clinical research. Premium Research Peptide.

    1000 in stock

    🔥 Exclusive Crypto Offer

    Get an INSTANT 15% DISCOUNT when you pay with Bitcoin, Ethereum, Dogecoin, Bitcoin Cash, XRP, Solana, or USDT.

    âš¡ Don't have crypto? Buy it here in 5 minutes with easy guidance.

    💡 Pro Tip: You can also pay with cryptocurrency using your verified Cash App or PayPal account for a fast and secure checkout!

    SKU: am-1785210817227-23 Category:

      Certificate of Analysis

      Third Party Tested • ISO/IEC 17025 Accredited • Premium Quality

      Purity: 99.53% (✓ Passed Full QC Panel)

      Semax 10mg Specification

      Variant Semax 10mg
      Lot # SMX0001
      Labeled 10mg
      Actual 10.53mg
      Tested May 29, 2026
      Full QC Panel 7× tested
      Purity (HPLC) 99.53%
      Net Peptide Content 10.53mg
      Identity (HPLC) Semax
      HPLC Conformity mean 99.40%
      Heavy Metals (ICP-MS) Not Detected
      Sterility (PCR) No Growth
      Endotoxin (USP <85>) < 0.05 EU/mLISO/IEC 17025 Accredited

      Frequently Researched Together

      Neuropeptide research compounds

      Molecular Profile

      What Is Semax?

      Synthetic heptapeptide analog of ACTH (4-10) with C-terminal Pro-Gly-Pro extension for enhanced stability

      HeptapeptideACTH Analog

      Type Synthetic heptapeptide
      CAS Number 80714-61-0
      Molecular Formula C37H51N9O10S
      Molecular Weight 813.9 g/mol
      Amino Acids 7 residues
      Sequence Met-Glu-His-Phe-Pro-Gly-Pro
      PubChem Database

      Storage Requirements

      Stability Information

      Handle with care to maintain potency

      Development Status

      Regulatory Information

      Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences

      Developer Russian Academy of SciencesApprovalRussia (1990s)
      Indication sStroke, cognitive impairmentFormulations0.1% and 1% nasal sprayUS StatusNot FDA-approvedRelated PeptideSelank (tuftsin analog)Wikipedia